Adalimumab/infliximab/thalidomideDevelopment of antibodies to drug and neuropathy: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1727卷 / 1期

关键词：

D O I：

10.1007/s40278-018-54003-0

中图分类号：

学科分类号：

摘要：

引用

页码：18 / 18

共 50 条

[31] Severe anaphylactic reaction to infliximab: successful treatment with adalimumab - report of a case
Stallmach, A
Giese, T
Schmidt, C
Meuer, SC
Zeuzem, SS
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (06) : 627 - 630
[32] Adalimumab/infliximab/ustekinumabMalignant melanoma, allergic reaction and polyneuropathy: case report
Reactions Weekly, 2023, 1960 (1) : 21 - 21
[33] Adalimumab/AzathioprineDrug intolerance and iatrogenic optic neuropathy: case report
Reactions Weekly, 2025, 2051 (1) : 19 - 19
[34] Adalimumab/infliximabStress fracture (first report with infliximab): 2 case reports
Reactions Weekly, 2006, 1100 (1) : 6 - 7
[35] Adalimumab/infliximabDevelopment of drug resistance: case report
Reactions Weekly, 2022, 1893 (1) : 18 - 18
[36] Adalimumab/thalidomideSensitive peripheral neuropathy and pulmonary sarcoidosis: case report
Reactions Weekly, 2019, 1772 (1) : 17 - 17
[37] AdalimumabDevelopment of anti-adalimumab antibodies: case report
Reactions Weekly, 2018, 1732 (1) : 22 - 22
[38] Infliximab and anterior optic neuropathy: case report and review of the literature
Jane W. Chan
Alberto Castellanos
Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 283 - 287
[39] Infliximab and anterior optic neuropathy: case report and review of the literature
Chan, Jane W.
Castellanos, Alberto
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (02) : 283 - 287
[40] Risk factors for the development of anti-drug antibodies to infliximab and adalimumab in Crohn's disease
Khoo, E.
Lord, A.
Hanigan, K.
Croft, A.
Radford-Smith, G.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S378 - S379

← 1 2 3 4 5 →